Doug Nissinoff is the Founder and General Partner (also listed as Managing Director) of Intelligence Ventures. See contact routes.
Doug Nissinoff is the Founder and General Partner (also listed as Managing Director) of Intelligence Ventures, an early-stage venture firm he launched in December 2022 after working in clinical research and investor relations for biotech companies. His investment thesis targets pre-seed and seed-stage startups in the United States and Canada that apply artificial intelligence to four healthcare verticals: biotech/pharma tools, medical devices, diagnostics, and healthcare SaaS. The fund typically writes checks between $50,000 and $250,000, with Nissinoff emphasizing backing technical founders building defensible technology over hype-driven “AI-washed” startups. While specific portfolio company names are not detailed in the available search results, the firm’s focus includes AI-powered platforms for drug research optimization, hardware solutions with integrated AI, and data-driven clinical workflow software. Nissinoff distinguishes himself by prioritizing real, technical innovation in AI-healthcare intersections rather than superficial AI applications, a viewpoint highlighted in his podcast interview on investing in AI and healthcare. He also serves as Chief B
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Fort Lauderdale.
Investors like Doug Nissinoff · Full investor directory · Investor access · Company funding database